[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368382-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368382-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","loss-of-chromosome-y-is-unrelated-to-the-composition-of-the-tumor-microenvironment-and-patient-prognosis-in-muscle-invasive-urothelial-bladder-cancers","Loss of chromosome Y is unrelated to the composition of the tumor microenvironment and patient prognosis in muscle-invasive urothelial bladder cancers","","Loss of chromosome Y (LOY) has been proposed as a driver of bladder cancer aggressiveness, T-cell dysfunction, and poor outcomes. Fluorescence in-situ hybridization measured chromosome Y status on a tissue microarray of 2,071 male urothelial carcinomas, including 487 muscle-invasive cases with available follow-up, while tumor microenvironment data were drawn from a prior study. LOY frequency showed limited, mostly nonsignificant associations with stage, and among pT2-4 tumors related to venous invasion only. Survival and immune cell infiltration did not differ meaningfully, arguing against a causal role of LOY in progression or immune reactions.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/loss-of-chromosome-y-is-unrelated-to-the-composition-of-the-tumor-microenvironment-and-patient-prognosis-in-muscle-invasive-urothelial-bladder-cancers/368382/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/loss-of-chromosome-y-is-unrelated-to-the-composition-of-the-tumor-microenvironment-and-patient-prognosis-in-muscle-invasive-urothelial-bladder-cancers/368382.png","ImageObject",300,407,{"name":42,"@type":43},"Margaret","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study address about loss of chromosome Y (LOY) in bladder cancer?","Question",{"text":63,"@type":64},"Whether LOY is linked to the tumor microenvironment composition and patient prognosis in muscle-invasive urothelial bladder cancers.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was LOY assessed and what patient cohort was used?",{"text":68,"@type":64},"Chromosome Y was analyzed using fluorescence in-situ hybridization on a tissue microarray containing 2,071 urothelial carcinomas from male patients, including 487 muscle-invasive cases with follow-up.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the results show regarding LOY and cancer progression, immune reactions, and survival?",{"text":72,"@type":64},"LOY was not clearly associated with histopathological aggressiveness, prognosis, or tumor microenvironment parameters, and muscle-invasive tumors with and without LOY showed no significant differences in key immune cell populations or survival outcomes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368382,1790462356,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":116,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},137451207643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Plage et al. BMC Cancer (2025) 25:677 [https://doi.org/10.1186/s12885-025-14019-w](https://doi.org/10.1186/s12885-025-14019-w)  \nBMC Cancer  \n RESEARCH Open Access  \nLoss of chromosome Y is unrelated    \nto the composition of the tumor microenvironment and patient prognosis in muscle-invasive urothelial bladder cancers  \nHenning Plage1, Viktoria Ahlburg2, Sebastian Hofbauer 1, Kira Furlano 1, Sarah Weinberger1, Annika Fendler 1, Florian Roßner3, Simon Schallenberg3, Sefer Elezkurtaj3, Niclas C. Blessin2, Maximilian Lennartz2, Andreas H. Marx4, Henrik Samtleben4, Margit Fisch5, Michael Rink6, Marcin Slojewski7, Krystian Kaczmarek7, Thorsten Ecke8, Stefan Koch9, Nico Adamini10, Ronald Simon2, Guido Sauter2, Henrik Zecha10,  \nJoachim Weischenfeldt1,11, Tobias Klatte8, Sarah Minner2, David Horst3, Thorsten Schlomm 1 and Martina Kluth2*  \nAbstract  \nBackground Loss of chromosome Y (LOY) has recently been proposed to be associated with cancer aggressiveness, altered T-cell function, and poor prognosis in bladder carcinomas.  \nMethods Chromosome Y was analyzed using fluorescence in-situ hybridization on a tissue microarray containing 2,071 urothelial carcinomas ofthe urinary bladder from male patients, including 487 patients who had undergone cystectomy for muscle-invasive disease and for whom follow-up data were available. Data on tumor microenvironment were obtained from a previous study.  \nResults LOY was found in 26. 0% of 1,704 analyzable cancers. In non-invasive cancers, LOY frequency was comparable in pTa G2 (22 . 8%) and pTa G3 (24 . 1%, p = 0 . 8036) carcinomas and slightly increased from pTa to pT2-4 carcinomas (23 . 1% for pTa and 27 . 2% for pT2-4) but these differences were not significant (p = 0 . 0794) . In muscle-invasive cancers, LOY frequency slightly increased from pT2 (25 . 5%) to pT4 cancers (33 . 0%), but this association was not significant (p = 0 . 1814) . Among pT2-4 cancers, LOY was associated with venous invasion (p = 0 . 0010) but unrelated to pT, pN, and L-status, as well as to overall, recurrence-free, and cancer-specific survival. Muscle-invasive urothelial carcinomas with and without LOY did not show significant differences in the number of CD8 positive lymphocytes, fraction of CD8 positive intraepithelial lymphocytes, number of macrophages and dendritic cells, and fraction ofT helper and T regulatory cells.  \nConclusion The lack of a clear association of LOY with histopathological parameters of cancer aggressiveness, patient prognosis, and parameters describing the tumor microenvironment strongly argues against the driving role of LOYin bladder cancer progression and cancer-associated immune reactions.  \nKeywords Loss of chromosome Y, Tissue microarray , Urothelial bladder cancer, Tumor microenvironment  \n*Correspondence: Martina Kluth[m.kluth@uke.de](m.kluth@uke.de)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nPlage et al. BMC Cancer (2025) 25:677  \nIntroduction  \nSex disparities in the incidence and mortality rates of","cbCail2Fr6qCWpUY","https://ap.wps.com/l/cbCail2Fr6qCWpUY","pdf",2837210,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What question does the study address about loss of chromosome Y (LOY) in bladder cancer?\",\"answer\":\"Whether LOY is linked to the tumor microenvironment composition and patient prognosis in muscle-invasive urothelial bladder cancers.\"},{\"question\":\"How was LOY assessed and what patient cohort was used?\",\"answer\":\"Chromosome Y was analyzed using fluorescence in-situ hybridization on a tissue microarray containing 2,071 urothelial carcinomas from male patients, including 487 muscle-invasive cases with follow-up.\"},{\"question\":\"What did the results show regarding LOY and cancer progression, immune reactions, and survival?\",\"answer\":\"LOY was not clearly associated with histopathological aggressiveness, prognosis, or tumor microenvironment parameters, and muscle-invasive tumors with and without LOY showed no significant differences in key immune cell populations or survival outcomes.\"}]","Loss of chromosome Y is unrelated to the composition of the tumor microenvironment and patient prognosis in muscle-invasive urothelial bladder cancers | PDF",1790176640,23,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/83d45b90e1ddafb7f246a9f713c0af8a.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0ce30824b55e389351ba741c36f33cfd.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5bc56debd4316408313d39f7347a4d13.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b7df2b88a5ad853846849d5a972a1e88.webp",980,1301]